| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.096 | 0.04 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.084 | 0.04 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.096 | 0.05 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.088 | 0.06 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.082 | 0.06 |